Harvard-Backed Program Drops 'Students Of Color' Requirement After Legal Complaint Authored by Anna Poff via The College Fix, A Harvard-backed summer scholarship program accused of racial discrimination quietly revised its eligibility language after a legal complaint, but critics told The College Fix the change came too late. The Union Scholars summer scholarship program is headed by the American ...
Harvard-Backed Program Drops 'Students Of Color' Requirement After Legal Complaint Authored by Anna Poff via The College Fix, A Harvard-backed summer scholarship program accused of racial discrimination quietly revised its eligibility language after a legal complaint, but critics told The College Fix the change came too late. The Union Scholars summer scholarship program is headed by the American Federation of State, County, and Municipal Employees, with support from Harvard University, including the use of its facilities and a partnership with the school’s Center for Labor and a Just Economy and the Wurf Fund, according to a federal complaint from the Equal Protection Project . “After we filed the complaint and it was reported in The NY Post , AFSCME changed its website to remove the ‘students of color’ language – but that’s too late and too little,” EPP President William Jacobson told The College Fix via email. “The program itself is intended for students of color, the website just said the quiet part out loud. This program still violates the law even though they are trying to hide the evidence,” he said. Jacobson also said that “The removal of incriminating language after the complaint was filed reflects a consciousness of guilt – there would be no reason to change the website if the program didn’t discriminate.” He added that “the Harvard programs must be open without regard to race as a matter of law and common decency.” The program is “a summer scholarship and internship opportunity” for students who want to promote “social and economic justice,” according to its website. “Like our union, the program supports our vision of growing a diverse union movement founded on principles of inclusivity,” the website states. It takes place over seven weeks in the summer, including a four-day orientation followed by six weeks of field placement at a “union organizing campaign in one of several locations across the United States.” A disclaimer at the bottom of the website s...
"The US are maybe sanctioning and reprimanding other economies and slapping tariffs on countries that are doing deals with China but the US itself may well do a deal with China. In fact we expect that this year," Mr Torrens told the BBC.
"The US are maybe sanctioning and reprimanding other economies and slapping tariffs on countries that are doing deals with China but the US itself may well do a deal with China. In fact we expect that this year," Mr Torrens told the BBC.
Earnings Call Insights: KLA Corporation (KLAC) Q2 2026 Management View CEO Richard Wallace highlighted that for 2025, KLA delivered 17% revenue growth to $12.745 billion, with process control systems revenue up 19% and service business up 15%. He stated, "Earnings per share grew 29% year-over-year, demonstrating the strong leverage in our model, and KLA maintained industry-leading gross margins an...
Earnings Call Insights: KLA Corporation (KLAC) Q2 2026 Management View CEO Richard Wallace highlighted that for 2025, KLA delivered 17% revenue growth to $12.745 billion, with process control systems revenue up 19% and service business up 15%. He stated, "Earnings per share grew 29% year-over-year, demonstrating the strong leverage in our model, and KLA maintained industry-leading gross margins and operating margins of 62.8% and 43.6%, respectively." Wallace also noted, "AI remains a core driver of KLA's performance and a key factor in our growing industry leadership." Wallace reported that advanced packaging revenue reached approximately $950 million in 2025, representing over 70% year-over-year growth, and projected that "as we look forward to calendar 2026, we expect this momentum to continue with year-over-year percentage growth expectations in the mid- to high teens." He emphasized, "Quarterly free cash flow was a record $1.26 billion. Total capital returned in the December quarter was $797 million, comprised of $548 million in share repurchase and $250 million in dividends." CFO Bren Higgins stated, "Revenue was $3.3 billion, above the guidance midpoint of $3.225 billion. Non-GAAP diluted EPS was $8.85 and GAAP diluted EPS was $8.68, each above the midpoint of the respective guidance ranges. Gross margin was 62.6%, 60 basis points above the midpoint of guidance due to stronger-than-modeled service performance and manufacturing efficiencies." Higgins noted, "The company had 132 million diluted weighted average shares outstanding for the quarter." Outlook Higgins projected, "The industry outlook for 2026 has strengthened over the past few months. We expect the core WFE market to grow in the high single to low double digits, reaching the low $120 billion range, up from approximately $110 billion in 2025." He added, "We expect the advanced packaging component of the market to grow at a similar rate to approximately $12 billion for a total market forecast in the mi...
winhorse/iStock Unreleased via Getty Images Coca-Cola ( KO ) remains one of the most popular brands globally, as mentioned in my last write up that, around 94% of the global population recognises the logo. Seeking Alpha The stock hasn't moved much since my last article, as it has underperformed; the S&P 500 continues to outperform, consistent with past performance. As the index is hitting all time...
winhorse/iStock Unreleased via Getty Images Coca-Cola ( KO ) remains one of the most popular brands globally, as mentioned in my last write up that, around 94% of the global population recognises the logo. Seeking Alpha The stock hasn't moved much since my last article, as it has underperformed; the S&P 500 continues to outperform, consistent with past performance. As the index is hitting all time highs, Coca-Cola is also now trading near all time highs at the time of writing, around 2% off the all time high. I continue to believe that the opportunity cost for holding Coca-Cola exists as the bull market continues to run, as analysts remain bullish for 2026, such as JP Morgan's 2026 market outlook . I believe next quarter is important for Coca-Cola, as price increases are currently driving growth, rather than volume increases, as Coca-Cola suffers the fate of being 'too popular', as there is no new customer base to expand to. With new disruptors like Celsius, obviously not directly competing with Coca-Cola's core drink, Cola, should continue to be concerning to investors with the shift away from sugary drinks, as though Coca-Cola offers Diet Coke or Coke Zero, might start showing signs of a shift from drinks that taste sugary rather than just containing sugar. With limited upside, I continue to rate Coca-Cola at a 'Hold', remaining one of the best defensive stocks in the market, especially with tariff threats benefitting the stock rather than harming it (January-April 2025). The Shift from Sugary Drinks As people become more health conscious about what they eat daily, many products have been modified to fit consumers' tastes, such as decaf coffee or caffeine-free soda, and a key thing in many food products and beverages is sugar. In the UK , over 7 out of every 10 soft drinks sold are low or no sugar. Volumes of sugary soft drinks in takeaways fell from 2016 to 2025, as the general consensus is a fall in sales of sugary drinks, as companies adapt to more non-sugary d...
中国医药产业国际化往高附加值升级。 一直以来，中国是原料药出口大国，而西药产品出口如何往更高附加值方向发展，颇受关注。 中国医药保健品进出口商会1月29日公众号发布的数据显示，2025年，中国西药制剂出口金额为88.41亿美元，同比增长27.29%。其中制剂出口金额占西药产品出口的比重首次达到15.85%的历史高位。 此外，2025年，制剂出口金额占医药产品整体出口的比重达到7.94%，也呈现出明显上升的趋势，反映了中国医药产业国际化不断由上游中间体、原料药向下游制剂等高附加值领域的升级。 2025年，中国西药制剂出口整体表现出“量价齐升”的态势，制剂出口数量同比增长17.71%，出口单价同比增长8.01%。 从地区市场看，对欧盟（不含英国）出口仍然占比最高，同比增长70.4%，相较2024年上升了约10个百分点，其中对法国出口增长281.82%，对丹麦出口增长19.39%，对意大利出口增长488.89%。 受加征关税的影响，对美出口制剂金额占制剂出口比重降至13.14%，较2024年下跌了约3.4个百分点。 整体看，驱动2025年中国制剂出口大幅增长的品类，当属激素类药品，出口金额31.53亿美元，同比增长106.00%。其中，包括各胰岛素类似物和GLP-1多肽类药物等在内的制剂出口金额29.77亿美元，同比增长110.90%，是激素类药品出口的主要增量。此类药品出口中，对法国出口同比增长468.88%，对丹麦出口同比增长19.40%，同时构成了制剂对欧盟出口的主要增长贡献。此外，重组人胰岛素制剂出口金额8237万美元，同比增长87.66%。 中国医药保健品进出口商会方面表示，究其原因，主要受益于全球糖尿病、肥胖症等代谢性疾病发病率上升带来的胰岛素类似物及GLP-1类药物需求激增，一方面得益于跨国企业深化在华发展战略，从早期仅注重于成品制剂进口分享中国市场红利的“in China for China（立足中国，服务中国）”，到持续加码布局在华制剂生产业务的“in China for global（立足中国，服务全球）”，跨国药企将中国作为全球供应链布局的重要基地；另一方面，本土企业在胰岛素类似物、GLP-1多肽类药物等领域实现技术突破与产能释放，不断有企业将产品以各种形式出海新兴市场并实现商业化，也开始尝试向FDA（美国食品药品监督管理局）、EMA（欧洲药品管理局...
Advertisement Broadcom’s recent share performance and fundamentals Broadcom (AVGO) has drawn investor attention after a mixed stretch in its share price, with a small 1 day decline and gains over the past week, set against weaker month and past 3 months returns. At a last close of US$330.73, Broadcom sits alongside reported revenue of US$63.9b and net income of US$23.1b, giving investors substanti...
Advertisement Broadcom’s recent share performance and fundamentals Broadcom (AVGO) has drawn investor attention after a mixed stretch in its share price, with a small 1 day decline and gains over the past week, set against weaker month and past 3 months returns. At a last close of US$330.73, Broadcom sits alongside reported revenue of US$63.9b and net income of US$23.1b, giving investors substantial current financial scale to weigh against its recent share price moves. Broadcom’s recent 7 day share price gain sits against weaker 1 month and 3 month share price returns, while its 1 year total shareholder return above 50% and very large 5 year total shareholder return suggest long term momentum has been strong even as shorter term sentiment has cooled. If Broadcom’s move has you reassessing your tech exposure, it may be worth scanning as a next step to spot other opportunities in the sector. With Broadcom’s strong recent financial scale, mixed short term returns and a value score of 1, the key question is whether the current price still leaves upside on the table or whether markets are already fully pricing in future growth. Most Popular Narrative: 31.1% Undervalued According to oscargarcia, the most followed narrative puts Broadcom’s fair value at $480, well above the last close of $330.73, with AI infrastructure and software scale doing much of the heavy lifting in that view. Broadcom is no longer just a chipmaker; it is a full-stack AI and infrastructure provider, blending hardware and software seamlessly. Its ambition is to dominate AI-specific custom silicon and enterprise-grade cloud software. Curious what revenue mix, margin profile and future profit multiple are baked into that $480 figure? The narrative leans heavily on accelerating AI demand and high margin software scale, plus a punchy valuation multiple that assumes Broadcom keeps converting that growth into very large cash generation. Result: Fair Value of $480 (UNDERVALUED) However, customer concentratio...
Dolby Laboratories NYSE: DLB reported a strong start to fiscal 2026, with first-quarter revenue and non-GAAP earnings per share coming in above the high end of the company’s prior guidance. Management attributed the outperformance primarily to deal timing and a favorable shipment true-up, while also pointing to progress across several growth initiatives in automotive, television, mobile, and strea...
Dolby Laboratories NYSE: DLB reported a strong start to fiscal 2026, with first-quarter revenue and non-GAAP earnings per share coming in above the high end of the company’s prior guidance. Management attributed the outperformance primarily to deal timing and a favorable shipment true-up, while also pointing to progress across several growth initiatives in automotive, television, mobile, and streaming-related programs. Get Dolby Laboratories alerts: Sign Up First-quarter results beat guidance For the first quarter of fiscal 2026, Dolby posted revenue of $347 million, which CFO Robert Park said was above the high end of the company’s guidance range. Park said the upside was driven “primarily” by the timing of deals arriving earlier than expected and a $7 million favorable true-up for Q4 shipments. Non-GAAP earnings per share was $1.06, also above guidance, which Park attributed to higher revenue and lower operating expenses. Licensing revenue totaled $320 million, while product and services revenue was $27 million. The company generated approximately $55 million in operating cash flow, repurchased $70 million of common stock, and ended the quarter with about $207 million remaining on its share repurchase authorization. Dolby also declared a $0.36 dividend, which Park noted was up 9% from the dividend a year earlier, and finished the quarter with approximately $730 million in cash and investments. Park added that GAAP operating expenses in the quarter included a $10 million restructuring charge as the company continues to streamline operations and align resources with business priorities. Automotive and TV initiatives highlighted at CES CEO Kevin Yeaman said the company used CES to showcase how Dolby Atmos and Dolby Vision are influencing entertainment experiences across movies, TV, music, sports, and user-generated content, with demonstrations focused “primarily” on in-car entertainment and Dolby Vision 2 for televisions. Yeaman described automotive as a growing focu...
Celestica NYSE: CLS reported what executives called “very strong” fourth-quarter results for fiscal 2025, driven primarily by growth in its Connectivity & Cloud Solutions (CCS) segment across communications and enterprise end markets. Management said both revenue and adjusted earnings per share exceeded the high end of the company’s guidance, while adjusted operating margin of 7.7% marked the stro...
Celestica NYSE: CLS reported what executives called “very strong” fourth-quarter results for fiscal 2025, driven primarily by growth in its Connectivity & Cloud Solutions (CCS) segment across communications and enterprise end markets. Management said both revenue and adjusted earnings per share exceeded the high end of the company’s guidance, while adjusted operating margin of 7.7% marked the strongest performance in company history. Get Celestica alerts: Sign Up Fourth-quarter and full-year results For the fourth quarter, Celestica posted revenue of $3.65 billion, up 44% year over year and above the high end of its guidance range. Non-GAAP operating margin was 7.7%, up 90 basis points, and adjusted EPS was $1.89, up $0.78, or 70%, also exceeding the top end of guidance. Additional quarterly metrics highlighted on the call included adjusted gross margin of 11.3% (up 30 basis points), an adjusted effective tax rate of 19%, and adjusted return on invested capital (ROIC) of 43%, up 14 percentage points versus the prior year. For the full year 2025, CEO Rob Mionis said the company delivered revenue of $12.4 billion and adjusted EPS of $6.05, representing growth of 28% and 56%, respectively. Adjusted operating margin was 7.5%, which management said reflected the second consecutive year of 100 basis points of improvement, driven by AI-related demand for data center technologies, operational execution, and operating leverage. Segment performance: CCS growth offsets ATS softness Chief Financial Officer Mandeep Chawla said CCS revenue in the quarter rose 64% to $2.86 billion and represented 78% of total company revenue. Growth was driven by “very solid” performance in both communications and enterprise end markets. Communications end market: Revenue increased 79%, above guidance for high-60s% growth, primarily driven by demand and ramping programs for 800G networking switches across the company’s largest hyperscaler customers. Revenue increased 79%, above guidance for high-6...